Professional background in the biopharma and life sciences industry, with experience in health economics and outcomes research (HEOR), clinical development, and regulatory affairs. Has contributed to various regulatory submission documents for both investigational and commercialized products, as well as conducted market research and systematic literature reviews for pipeline drugs in the neurological and rare disease spaces. Experience working on cross-functional teams within both large and small biotech companies. Holds a B.S. in Neuroscience and a Management minor from Boston College.
